Scadden David
SEC insider (Form 3/4/5 filer). CIK 0001707715. Director at AGIOS PHARMACEUTICALS, INC. (AGIO) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CAMBRIDGE, MA.
Companies Scadden David has filed insider reports for
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director
- Editas Medicine, Inc. (EDIT): Director
Scadden David
CIK: 0001707715
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.9K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.8K shares- - Jun 17, 2026EDIT
Editas Medicine, Inc.
AwardDirectStock Option (right to buy)
51.7K shares- - Nov 12, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect200 shares at avg. $18.09$4K - Nov 12, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect200 shares at avg. $43.84$9K - Oct 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect200 shares at avg. $41.00$8K - Oct 8, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect200 shares at avg. $18.09$4K - Sep 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
SaleDirect200 shares at avg. $40.00$8K - Sep 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect200 shares at avg. $18.09$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 14,950 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,927 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,816 | - | $0 | Direct |
| Jun 17, 2026 |  EDIT Editas Medicine, Inc. | Award Stock Option (right to buy) | 51,700 | - | - | Direct |
| Nov 12, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 200 | $18.09 | $3,618 | Direct |
| Nov 12, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 200 | $43.84 | $8,768 | Direct |
| Oct 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 200 | $41.00 | $8,200 | Direct |
| Oct 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 200 | $18.09 | $3,618 | Direct |
| Sep 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale | 200 | $40.00 | $8,000 | Direct |
| Sep 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 200 | $18.09 | $3,618 | Direct |
1-10 of 20 transactions